Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients.
Ryosuke NakamuraNoriaki ArakawaYoichi TanakaNahoko UchiyamaAkihiro SekineYoichi MashimoKeiji TsujiTatehiro KagawaKen SatoMasaaki WatanabeMitsuhiko AisoYoichi HiasaYoshiyuki TakeiHiromasa OhiraMinoru AyadaEri TsukagoshiKeiko MaekawaMasahiro TohkinYoshiro SaitoHajime TakikawaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2022)
HLA-B*35:01 is a genetic risk factor and a potential predictive biomarker for Kampo-induced DILI in the Japanese population.